Price
No data yet.
Social Signal Score
Analyst Ratings
5 analystsRevenue
$4.03B+65.84%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Gonzalo Maria Gortazar Rotaeche
- Sector
- Financial Services
- Industry
- Banks - Regional
- Employees
- 47,120
- Beta
- 0.11
- Country
- ES
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- 0.21
Financials
Revenue
$4.03B+65.8%Net Income
$1.63B+391.3%EBITDA
$2.25B+334.2%Free Cash Flow
$0.00-100.0%EPS (diluted)
$0.08+310.2%Shares Outstanding (diluted)
20.88B+17.8%Operating Expenses
$1.05BCash & Debt
$37.98BDividend per Share
$0.13Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $24.11B | $5.89B | $0.26 |
| 2024 | $26.83B | $5.79B | $0.25 |
| 2023 | $24.07B | $4.82B | $0.20 |
| 2022 | $15.22B | $3.13B | $0.12 |
| 2021 | $13.27B | $5.23B | $0.22 |
| 2020 | $10.99B | $1.38B | $0.07 |
| 2019 | $11.34B | $1.71B | $0.09 |
| 2018 | $11.41B | $1.99B | $0.11 |
| 2017 | $11.12B | $1.68B | $0.09 |
| 2016 | $10.72B | $1.05B | $0.06 |
| 2015 | $11.82B | $814.46M | $0.04 |
| 2014 | $11.86B | $620.02M | $0.04 |
| 2013 | $12.12B | $315.87M | $0.02 |
| 2012 | $11.86B | $229.70M | $0.02 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from CAIXY's reported EPS growth of 23.2% a year over 13 years.
- EPS in 5 years
- $0.79
- Implied price
- $10.30
- Return from $4.51
- 18.0% a year
To earn 15.0% a year on these assumptions you'd need to buy at $5.12 — today's price is already 11.9% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 9 | 11 | 13 | 15 | 17 |
|---|---|---|---|---|---|
| 13.2% | 0.7% | 4.8% | 8.4% | 11.5% | 14.4% |
| 18.2% | 5.1% | 9.4% | 13.2% | 16.5% | 19.4% |
| 23.2% | 9.6% | 14.1% | 18.0% | 21.4% | 24.5% |
| 28.2% | 14.0% | 18.7% | 22.7% | 26.3% | 29.5% |
| 33.2% | 18.5% | 23.3% | 27.5% | 31.2% | 34.6% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
80-33.33%Social Signal Score
Mentions (3)
- Newsreuters.com·5d ago·Negative
Caixabank to assess possible bid for BNP's Cetelem, newspaper reports Spanish lender Caixabank has hired Morgan Stanley to assess a potential acquisition of Cetelem, the Spanish and Portuguese consumer lending business owned by BNP Paribas , financial newspaper Expansion reported on Thursday.
View source ↗ - Newszacks.com·25d ago·Negative
Are You Looking for a Top Momentum Pick? Why CaixaBank, S.A. Does CaixaBank, S.A. Unsponsored ADR (CAIXY) have what it takes to be a top stock pick for momentum investors?
View source ↗ - Newsseekingalpha.com·56d ago·Positive
Caixabank: Taking My Profits After A Triple Digit Performance Caixabank offers focused Iberian exposure with strong recent performance and robust H1 2025 results. Net income rose 8.5% to €3.2B, supported by resilient net interest and fee income, especially in wealth management. CAIXY maintains a healthy 12.54% CET1 capital ratio, well above regulatory minimums, and continues disciplined capital returns via dividends and buybacks.
View source ↗
Earnings
Fri, Oct 30(in 3 weeks)
Consensus estimate $0.09 per share
Typical surprise +5.6% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Jul 28$0.09 vs $0.08beat
- Wed, Apr 29$0.08 vs $0.08beat
- Fri, Jan 30$0.08 vs $0.08beat
- Thu, Oct 30$0.08 vs $0.08beat
- Wed, Jul 30$0.08 vs $0.07beat
Estimates and results for CAIXY via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Congress trades
No disclosed congressional trades in CAIXY.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.